modelAmiodarone

Diagram of Amiodarone

Extends from Pharmacolibrary.Drugs.ATC.C.C01BD01.

Information

name:Amiodarone
ATC code:C01BD01
route:oral
compartments:2
dosage:400mg
volume of distribution:66L
clearance:0.14L/kg/h
other parameters in model implementation

Amiodarone is a class III antiarrhythmic agent primarily used for the treatment and prevention of various types of cardiac arrhythmias, including ventricular tachycardia and atrial fibrillation. It is approved for use in many countries but is reserved for life-threatening arrhythmias due to potential for serious side effects.

Pharmacokinetics

Pharmacokinetic parameters in adult healthy individuals or cardiac patients following oral administration.

References

  1. Lehnert, A, et al., & Treluyer, JM (2022). Amiodarone/N-desethylamiodarone population pharmacokinetics in paediatric patients. British journal of clinical pharmacology 88(12) 5369–5377. DOI:10.1111/bcp.15458 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35816412

  2. Pollak, PT, et al., & Shafer, SL (2000). Population pharmacokinetics of long-term oral amiodarone therapy. Clinical pharmacology and therapeutics 67(6) 642–652. DOI:10.1067/mcp.2000.107047 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10872646

  3. Hirai, T, et al., & Iwamoto, T (2022). Population Pharmacokinetic Model of Amiodarone and N-Desethylamiodarone Focusing on Glucocorticoid and Inflammation. Biological & pharmaceutical bulletin 45(7) 948–954. DOI:10.1248/bpb.b21-00940 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35786602

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)